L'Oréal has acquired a majority stake in British cosmetics company Medik8. Private equity fund Inflexion will remain a minority shareholder, while the current board of directors will also retain its functions.
The price of the stake has not been officially announced, but according to the Financial Times, the price of the deal is around EUR 1 billion.
L'Oréal's share price remained almost unchanged after the news.
L'Oréal is looking to cash in on the boom in science-based skincare products, thanks in part to influencers on social media.
Brands that are now part of the "Dermatology Beauty Department" include La Roche-Posay, Cerave, Vichy, Skinceuticals and Skinbetter Science.
This division generated revenues of more than €7 billion in 2024, representing almost 10% year-on-year growth and making it L'Oréal's fastest growing division.
Seeking to expand its portfolio, L'Oréal bought soap maker Aesop in 2023 and Korean beauty brand Dr.G in December.
Last year, L'Oréal also acquired a 10% stake in cosmetics company Galderma, as well as Miu Miu's cosmetics license. | BGNES